Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04156412
Other study ID # 2019/127/HP
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 2, 2020
Est. completion date October 2020

Study information

Verified date June 2020
Source University Hospital, Rouen
Contact Frédéric ANSELME, Pr
Phone +3323288
Email frederic.anselme@chu-rouen.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pilot study to evaluate the performance of a lead below 2 French with specific distal shape to deliver efficient LV pacing


Recruitment information / eligibility

Status Recruiting
Enrollment 28
Est. completion date October 2020
Est. primary completion date October 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male or female patient aged =18 years old.

- Patient presenting a CRT-P or CRT-D indication according to the latest ESC guidelines1.

- Primary implant of a CRT device (including upgrade from a single or dual-chamber pacemaker or ICD).

- Signed and dated informed consent.

Exclusion Criteria:

- Class IV of NYHA (ambulatory or not).

- Allergy to contrast media used for imaging during cardiac catheterization.

- Severe Renal Failure (clearance of creatinine according to Modification of diet in renal disease formula (MDRD) < 30ml/mn/m²).

- Previous failure of catheterization of the coronary sinus, or previous failure of left ventricular lead implantation.

- Already included in another clinical study involving intra-cardiac active implantable device, or participation to any other clinical trial in the last 2 weeks.

- Vulnerable patient such as person deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision).

- Known pregnancy, breastfeeding or women in childbearing age without an adequate contraceptive method with a known failure rate < 1%.-

Study Design


Related Conditions & MeSH terms

  • Cardiac Resynchronisation Therapy

Intervention

Device:
Implant test procedure
Implant test procedure with new LV quadripolar lead before a standard implantation for Cardiac resynchronisation therapy

Locations

Country Name City State
France Bordeaux University Hospital Bordeaux
France Clermont-Ferrand University Hospital Clermont-Ferrand
France Lille University Hospital Lille
France Rennes University Hospital Rennes
France Rouen University Hospital Rouen
Spain Hospital Universitari Germans Trias i Pujol Badalona
Spain Hospital Universitario y Politécnico La Fe Valencia

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Rouen MicroPort CRM

Countries where clinical trial is conducted

France,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary LV Bi-zone pacing success rate Percent of patients where the placement of the AXONE lead provides two distant LV pacing vectors matching: Pacing Threshold = 3.5V/0.5ms. 30 min
Primary LV pacing success rate Percent of patients where the placement of the AXONE lead allows at least one LV pacing vectors matching: Pacing Threshold = 3.5V/0.5ms. 30 min
Secondary Device or Implant testing procedure-related Adverse Events 1 month post intervention
Secondary Electrical performance (1) LV pacing threshold (Volt) 30 min
Secondary Electrical performance (2) LV pacing impedance (Ohm) 30 min
Secondary AXONE Implant Efficiency (1) procedure time for successful placement 30 min
Secondary AXONE Implant Efficiency (2) fluoroscopic time 30 min
Secondary AXONE Implant Efficiency (3) radiation dose 30 min
Secondary AXONE Implant Efficiency (4) handling assessment. 30 min
Secondary LV multipoint pacing success the placement of the AXONE provides two pacing vectors matching 30 min
See also
  Status Clinical Trial Phase
Recruiting NCT04376983 - Effect of Implant-based Telerehabilitation N/A
Recruiting NCT02814942 - Prospective Evaluation of Asians With CRT for Heart Failure
Completed NCT03750058 - Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy N/A
Recruiting NCT00472238 - Effects of Endurance Training on Patients With Reduced Left Ventricular Ejection Fraction (LVEF) and Cardiac Resynchronisation Therapy Especially for Cardiac Arrhythmias N/A